| Variables | Effectives |
| Mean age (years) | 32.32 ± 11.33 |
| Age groups (years) <20 20 - 40 40 - 60 >60 |
8 (8.2%) 60 (61.2%) 28 (28.6%) 2 (2%) |
| Gender (%) Men Women |
81 (82.7%) 17 (17.3%) |
| Protidemia (g/l) | 54.03 ± 11.87 |
| Albuminemia (g/l) | 1.25± 9.67 |
| Azotemia (g/l) | 0.62 ± 0.79 |
| Serum creatinine (mg/l) | 17.71 ± 23.77 |
| GFR (ml/min/1.73m2) | 89.88 ± 53.65 |
| Renal failure (%) | 27 (27.6%) |
| Hematuria (%) | 35 (35.7%) |
| Proteinuria (g/24h) | 4.11± 3.4 |
| Nephrotic syndrome (%) | 57 (58.2%) |
| C3 hypocomplementemia (%) | 5 (5.1%) |
| C4 hypocomplementemia (%) | 6 (6.1%) |
| CH50 hypocomplementemia (%) | 2 (2%) |
| Anti-DNA antibodies (%) | 33 (33.6%) |
| ANA (%) | 51 (52%) |
| Anti-Sm antibodies | 24 (24.48%) |
| Classes (%) I II III III + V IV IV + V V VI |
4 (4.1%) 9 (9.2%) 6 (6.1%) 11 (11.2%) 24 (24.5%) 10 (10.2%) 34 (34.7%) 0 (0%) |
| Immunosuppressants (%) Corticosteroids CYC MMF AZA RTX Cyclosporine |
94 (95.9%) 27 (27.6%) 38 (38.8%) 27 (27.6%) 1 (1%) 2 (2%) |